{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:55:27Z","timestamp":1766051727740,"version":"3.48.0"},"reference-count":25,"publisher":"Pensoft Publishers","issue":"6","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FM"],"abstract":"<jats:p>\n                    \ufeff\n                    <jats:bold>Abstract<\/jats:bold>\n                  <\/jats:p>\n                  <jats:p>Cystic fibrosis (CF) is diagnosed through a combination of clinical symptoms, a sweat test, and genetic analysis. Over the last five years, significant advances in cystic fibrosis treatment have been driven by a better understanding of the disease\u2019s genetic basis. This has enabled the development of more sophisticated genetic tests, allowing for more precise treatment for each individual patient.<\/jats:p>\n                  <jats:p>We present a case series of children with clinical presentations suggestive of cystic fibrosis, ambiguous sweat test results, and previous \u201cnegative\u201d genetic analysis results. More precise and advanced genetic testing revealed that all three patients carried two CF-causing mutations.<\/jats:p>\n                  <jats:p>In cases where there is high clinical suspicion, despite initial results indicating a negative outcome, we recommend the use of MLPA analysis for the detection of large deletions and insertions that cannot be detected by standard sequencing methods.<\/jats:p>","DOI":"10.3897\/folmed.67.e145379","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:52:22Z","timestamp":1766051542000},"source":"Crossref","is-referenced-by-count":0,"title":["The role of improved molecular genetic testing in the diagnosis of cystic fibrosis \u2013 a case series"],"prefix":"10.3897","volume":"67","author":[{"given":"Nadezhda","family":"Yaneva","sequence":"first","affiliation":[{"name":"University Hospital Maichin Dom, Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mila","family":"Baycheva","sequence":"additional","affiliation":[{"name":"Clinic of Pediatric Gastroenterology, Prof. Ivan Mitev University Hospital, Sofia, Bulgaria"},{"name":"Medical University of Sofia, Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2885-6479","authenticated-orcid":true,"given":"Dimitrinka","family":"Miteva","sequence":"additional","affiliation":[{"name":"Alexandrovska University Hospital, Sofia, Bulgaria"},{"name":"Medical University of Sofia, Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8168-742X","authenticated-orcid":true,"given":"Guergana","family":"Petrova","sequence":"additional","affiliation":[{"name":"Alexandrovska University Hospital, Sofia, Bulgaria"},{"name":"Medical University of Sofia, Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2258","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"145379_B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2023.09.008"},{"key":"145379_B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2024.01.012"},{"key":"145379_B3","doi-asserted-by":"crossref","unstructured":"3. Chun SW, Somers ME, Burgener EB. Highly effective cystic fibrosis transmembrane conductance (regulator) modulator therapy: shifting the curve for most while leaving some further behind. Curr Opin Pediatr 2024; 36(3):290\u20135.","DOI":"10.1097\/MOP.0000000000001338"},{"key":"145379_B4","doi-asserted-by":"publisher","DOI":"10.1002\/humu.10041"},{"key":"145379_B5","doi-asserted-by":"publisher","DOI":"10.3390\/genes11060589"},{"key":"145379_B6","unstructured":"6. Zolin A, Adamoli A, Bakkeheim E, et al. ECFSPR Annual Report 2022, published online 2024. Available from: https:\/\/www.ecfs.eu\/sites\/default\/files\/Annual%20Report_2022_ECFSPR_20240603.pdf (Accessed on 22 Dec 2024)."},{"key":"145379_B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijns10020038"},{"key":"145379_B8","unstructured":"8. CFTR2. F508del mutation general information [Internet]. CFTR2; [accessed on 22 December 2024]. Available from: https:\/\/cftr2.org\/mutation\/general\/F508del\/."},{"key":"145379_B9","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.696"},{"key":"145379_B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2007.00820.x"},{"key":"145379_B11","unstructured":"11. CFTR2. F508del mutation general information [Internet]. CFTR2; [accessed on 22 December 2024]. Available from: https:\/\/cftr2.org\/mutation\/scientific\/CFTRdele2\/."},{"key":"145379_B12","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0060-2024"},{"key":"145379_B13","doi-asserted-by":"publisher","DOI":"10.1590\/1806-3713\/e20180062"},{"key":"145379_B14","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2745"},{"key":"145379_B15","unstructured":"15. CFTR2. F508del mutation general information [Internet]. CFTR2; [accessed on 22 December 2024]. Available from: https:\/\/cftr2.org\/mutation\/general\/1525-1G-%253EA\/."},{"key":"145379_B16","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/50.2.120"},{"key":"145379_B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2013.07.001"},{"key":"145379_B18","unstructured":"18. CFTR2. F508del mutation general information [Internet]. CFTR2; [accessed on 22 December 2024]. Available from: https:\/\/cftr2.org\/mutation\/scientific\/S466X%253BR1070Q\/."},{"key":"145379_B19","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)00023-0"},{"key":"145379_B20","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20866"},{"key":"145379_B21","unstructured":"21. CFTR2. F508del mutation general information [Internet]. CFTR2; [accessed on 22 December 2024]. Available from: https:\/\/cftr2.org\/mutation\/scientific\/G1244E\/."},{"key":"145379_B22","doi-asserted-by":"publisher","DOI":"10.1046\/j.1529-8817.2004.00130.x"},{"key":"145379_B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2011.12.005"},{"key":"145379_B24","unstructured":"24. CFTR2. F508del mutation general information [Internet]. CFTR2; [accessed on 22 December 2024]. Available from: https:\/\/cftr2.org\/mutation\/scientific\/CFTRdele2%252C3\/."},{"key":"145379_B25","doi-asserted-by":"publisher","DOI":"10.1007\/s004390000246"}],"container-title":["Folia Medica"],"original-title":[],"link":[{"URL":"https:\/\/foliamedica.bg\/article\/145379\/download\/pdf\/","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/foliamedica.bg\/article\/145379\/download\/xml\/","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/foliamedica.bg\/article_preview.php?id=145379&skip_redirect=1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:52:26Z","timestamp":1766051546000},"score":1,"resource":{"primary":{"URL":"https:\/\/foliamedica.bg\/article\/145379\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12,18]]}},"URL":"https:\/\/doi.org\/10.3897\/folmed.67.e145379","relation":{},"ISSN":["1314-2143","0204-8043"],"issn-type":[{"value":"1314-2143","type":"electronic"},{"value":"0204-8043","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"article-number":"e145379"}}